Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Political Reporter Online.
Press releases published on April 24, 2025
America’s Last Safety Valve: Former CIA Advisor Reveals the Emergency Backstop Built into U.S. Law
GlobeNewswire
·
April 24, 2025
WASHINGTON, April 24, 2025 (GLOBE NEWSWIRE) -- What if the U.S. economy had a built-in pressure valve — a resource designed not for everyday use, but for a moment of national strain? According to Jim Rickards, former CIA advisor and veteran economic …
GENFIT Reports Full-Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
April 24, 2025
Cash and cash equivalents totaled €81.8 million as of December 31, 2024. In addition, completion in early 2025 of: (i) a non-dilutive royalty financing agreement for up to €185 million including a first installment of €130 million and (ii) the debt …
GENFIT : Résultats financiers annuels 2024 et point sur les activités de la Société
GlobeNewswire
·
April 24, 2025
Trésorerie et équivalents de trésorerie s’élevant à 81,8 millions d’euros au 31 décembre 2024. En outre, conclusion, en début d’année (i) d’un accord de royalty financing non dilutif d'un montant maximum de 185 millions d'euros comprenant un versement …
Inventiva announces the publication in Clinical Gastroenterology and Hepatology of its analysis of new biomarker signatures predictive of histological response in patients with MASH treated with lanifibranor
GlobeNewswire
·
April 24, 2025
► Biomarker signatures were developed to predict histological treatment response to lanifibranor treatment in patients with MASH and fibrosis ► The biomarker signatures developed for fibrosis improvement, MASH resolution and composite histological …
Inventiva annonce la publication dans Clinical Gastroenterology and Hepatology de l’analyse de nouvelles signatures de biomarqueurs prédictives de la réponse histologique chez les patients atteints de MASH traités par lanifibranor
GlobeNewswire
·
April 24, 2025
► Des signatures de biomarqueurs ont été développées pour prédire la réponse histologique au traitement par lanifibranor chez les patients atteints de MASH avec fibrose ► Les signatures de biomarqueurs développées pour l’amélioration de la fibrose, la …
Pacific Fusion and General Atomics Team Up to Deliver Breakthroughs in Inertial Fusion Energy
GlobeNewswire
·
April 24, 2025
FREMONT, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Pacific Fusion Corporation, which raised a >$900M series A in 2024 to power the world with abundant, affordable, and clean energy, is collaborating with fusion technology leader General Atomics (GA) to …
Atos completes reverse stock split
GlobeNewswire
·
April 24, 2025
Press release Atos completes reverse stock split Paris, France - April 24, 2025 – Atos SE (the “Company”) announces today the completion of the reverse stock split of the shares comprising its share capital, as decided by the Board of Directors on March 6, …
Atos finalise le regroupement de ses actions
GlobeNewswire
·
April 24, 2025
Communiqué de presse Atos finalise le regroupement de ses actions Paris, France – 24 avril 2025 – Atos SE (la « Société ») annonce aujourd’hui la finalisation du regroupement des actions composant son capital social, tel que décidé par le Conseil d’ …
Transaction in Own Shares
GlobeNewswire
·
April 24, 2025
Transaction in Own Shares 24 April, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 24 April 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading …
Sword Group: Q1 2025 Sword achieves its Double-Digit Growth Target despite the current Geopolitical Context: +11.8% (i)
GlobeNewswire
·
April 24, 2025
KEY FIGURES Consolidated revenue for the 1st quarter of 2025 is €85.5m, an increase of +11.8% on a like-for-like basis compared with the first quarter of 2024. Profitability (EBITDA margin) is 12.0%, or €10.3m. Q1 2025 ACCOUNTS Q1 | non audited figures €m …
Sword Group : 1er Trimestre 2025 | Sword réussit son objectif de croissance à 2 chiffres en dépit du contexte géopolitique actuel : +11,8 % (1)
GlobeNewswire
·
April 24, 2025
PRINCIPAUX CHIFFRES Le chiffre d’affaires consolidé du 1er trimestre 2025 est de 85,5 M€, en progression de +11,8 % à périmètre constant par rapport au 1er trimestre 2024. La rentabilité (marge d’EBITDA) est de 12,0 % soit 10,3 M€. COMPTES DU 1ER TRIMESTRE …
IT Link : Rapport Financier Annuel 2024 - Arrêté des comptes et mise à disposition du Rapport Financier Annuel
GlobeNewswire
·
April 24, 2025
Communiqué Financier Le Kremlin-Bicêtre, le 24 avril 2025 Arrêté des comptes par le Conseil d’Administration du 24 avril 2025 Comptes consolidés IT Link Groupe En M€ 2023 2024 Variation Chiffre d’Affaires 73,32 82,68 +12,8% Résultat …
Norsk Hydro: Primary insiders purchase shares under Long-Term Incentive program and shares to employees
GlobeNewswire
·
April 24, 2025
Members of Hydro’s Executive Leadership Team have received shares in Hydro via the Long-Term Incentive plan and purchased shares via the employee share purchase program. Long-Term Incentive plan Norsk Hydro ASA has a share-based Long-Term Incentive (LTI) …
Norsk Hydro: Primærinnsidere kjøper aksjer i langtidsinsentiv- og aksjer til ansatte-program
GlobeNewswire
·
April 24, 2025
Medlemmer av Hydros konsernledelse har mottatt aksjer i Hydros langtidsinsentivprogram og kjøpt aksjer via aksjekjøpsprogram for ansatte. Langtidsinsentivprogrammet Norsk Hydro ASA har et aksjebasert langtidsinsentivprogram («LTI») i form av en maksimal …
Cegedim: Like-for-like revenues grew 4.5% in the first quarter
GlobeNewswire
·
April 24, 2025
Quarterly financial information as of March 31, 2025 IFRS - Regulated information - Not audited Revenue grew 3.5% as reported and 4.5% LFL to €161.3 million in the first quarter of 2025. The marketing, health insurance, HR, and cloud businesses delivered …
Cegedim : Croissance organique de 4,5 % au premier trimestre
GlobeNewswire
·
April 24, 2025
Information financière trimestrielle au 31 mars 2025 IFRS – Information réglementée – Non auditée Chiffre d’affaires de 161,3 millions d’euros au premier trimestre 2025, en croissance publiée de 3,5 % et 4,5 % en organique Les activités de Marketing, d’ …
Guerbet: Q1 2025 revenue
GlobeNewswire
·
April 24, 2025
Q1 2025 revenue Quarterly activity Revenue: €180.1m, down 7.1% at CER1 and on a like-for-like basis2 As expected, a first quarter marked by a persistent impact on France and a penalizing base effect Declining momentum in Diagnostic Imaging (-8.7% at CER …
GUERBET: Chiffre d’affaires du 1er trimestre 2025
GlobeNewswire
·
April 24, 2025
Chiffre d’affaires du 1er trimestre 2025 Activité trimestrielle Chiffre d’affaires : 180,1 M€, en repli de 7,1% à TCC1 et périmètre comparable2 Comme anticipé, un premier trimestre marqué par un impact France persistant et un effet de base pénalisant Une …
Transgene Provides Business and Financial Update for Q1 2025
GlobeNewswire
·
April 24, 2025
TG4050: Updated randomized Phase I data to be presented in Rapid Oral Presentation at ASCO 2025 Dr. Simone Steiner appointed Chief Technical Officer (CTO) Business funded until the end of April 2026 Strasbourg, France, April 24, 2025, 5:45 p.m. CET – …
Transgene fait le point sur ses activités et sa situation financière au premier trimestre 2025
GlobeNewswire
·
April 24, 2025
TG4050 : Communication de nouvelles données de la partie Phase I randomisée lors d’une présentation orale rapide à l’ASCO 2025 Nomination du Dr Simone Steiner, Directrice des opérations techniques (CTO) La Société est financée jusqu’à fin avril 2026 …